We observed that oxaliplatin could significantly inhibit proliferation of these two CRC cells (Fig. 7B-C), but only UCA1, MIR22HG, MIR17HG showed significantly different after oxaliplatin treatment in both cell lines (Fig. 7D). The gene discussed is MIR17HG; the disease is colorectal carcinoma.